BIFIDO Co., Ltd.

Founded in 1999 to pursue the best biotechnology in the field of the human microbiome, Bifido has focused its research and development on Bifidobacterium species, considered among the most beneficial bacteria for maintaining healthy intestinal microbial balance, backed by more than 178 scientific papers and 70 patents establishing the company's experience and expertise in the microbiome industry. The company has more recently expanded into microbiome research on rheumatoid arthritis, analyzing patient microbiota and identifying novel Bifidobacterium strains that improve symptoms in animal models, with an eye toward new pharmabiotic products.